Active Ingredient(s)
OLIGOPEPTIDE-10
OLIGOPEPTIDE-10
1. Infiltrate the inner wall of clogged pores, dredge and remove impurities, promote circulation and help remove excess sebum.
2. Effectively separate the intercellular binding between dead skin cells, and make it easy to be removed from the skin surface.
1.Press lightly for 3-5 sec.to make sure the acne patch is sticking securely
2.Leave it for few hours for better results
3.Depending on the whitehead, use another patch to pull out gunk
Please keep out of reach of children.Do not swallow.Please clean your hands before use to ensure the best results from the product.Discontinue use if signs of irritation or rash occur.Store in a cool and dry place.
Discontinue use if signs of irritation or rash occur.
Discontinue use if signs of irritation or rash occur.
Please keep out of reach of children. Do not swallow.
Store in a cool and dry place.
HYALURONIC ACID、PANTOTHENIC ACID、NIACINAMIDE、SILICON DIOXIDE
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84660-060-01 | OUHOE Acne Atelier Microneedles Patch | 72 mg in 1 BOX | PATCH | 72 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 84660-060 | 84660-060-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| OLIGOPEPTIDE-10 | Q46328TRNK | ACTIB |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| PANTOTHENIC ACID | 19F5HK2737 | IACT |
| NIACINAMIDE | 25X51I8RD4 | IACT |
| HYALURONIC ACID | S270N0TRQY | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 25d6a85f-1248-0c6e-e063-6394a90a35b3 | 25d6a85f-1247-0c6e-e063-6394a90a35b3 | 2024-11-01 | Warnings | 25d6a85f-1248-0c6e-e063-6394a90a35b3 25d6a85f-1247-0c6e-e063-6394a90a35b3 |
Adverse event summaries are temporarily unavailable. Other product information remains available.